Pharmaceutical manufacturers can realize value by carefully and methodically reducing inventory, reducing the amount of drugs that expire, and reducing counterfeits in their supply chain, all by using a supply chain network solution. Here we describe the mechanisms and estimate the value of those improvements.
Countries with over half the world’s population go to the polls this year. While none of these elections represent absolute good vs. evil, the outcomes will still make a big difference. In this global tug-of-war of ideas and institutions between democracy and autocracy, much is at stake for all of humanity, including peoples’ rights and liberties, the rules-based global order, world peace, and global prosperity.
Vital decisions in 2024 will affect all of humanity in areas such as democracy vs. autocracy, the future of AI, and dealing with disinformation. In this first article in the series, we focus on AI, which is poised to provide enormous benefits for mankind. At the same time, it presents considerable known issues right now; and speculative very-high-consequence risks in the future. Here we discuss why 2024 will be a pivotal year, setting the direction for how mankind addresses those near-term issues and longer-term risks, with implications for decades to come.
We estimate the value that a multi-enterprise supply chain network could potentially provide via patient adherence and ease of doing business improvements. The value is quantified for a hypothetical archetypal pharmaceutical manufacturer. We elucidate the key metrics improved, mechanisms of improvement, and typical improvement range expected.
As we begin 2024, the global economy faces heightened maritime risk vis-à-vis climate and geopolitical crises in the Panama Canal Zone, Red Sea, and Baltic Sea, on top of persistent maritime risks in the Middle East, East Asia, and Arctic Circle. Supply chain procurement leaders need to implement strategies and best practices to improvise, adapt, and overcome disruptions to global supply chains and shipping capacity in order to drive resilience through the global economy in 2024.
ESG investment claims to leverage financial markets in service of society and to reduce company risk. However, considerable doubts have been expressed about how effective ESG indices and investment actually are in driving meaningful changes. How can investors make informed investment choices to further their lofty goals? Data and reporting frameworks are the mechanisms to link ESG action to impact. Addressing inaccuracies and greenwashing in data and reporting can deliver the substantial potential value to financial risk and social value of ESG investment.
We propose and specify a hypothetical multi-enterprise supply chain application network with functionality for track and trace/recall, cold chain, inventory management, patient adherence, and identity management. Then we estimate the potential value of using such a network for an archetypal pharmaceutical manufacturer.
Global ESG and supply chain regulations are driving companies to implement multi-tier supply chain mapping and traceability within certain industries. Here we discuss some impacts of those regulatory requirements on companies’ processes and systems.
Pharmaceutical supply chains face a number of challenges that could be mitigated by the adoption of multi-enterprise supply chain application network technology. Here we describe the structure of pharmaceutical supply chains and key challenges faced, such as: diverse and divergent incentives among different supply chain participants, complexity and opacity of product and financial flows, strict regulations, perishable products, and elusive patient adherence.
This article series looks at the potential opportunities of ESG investment – both for profitability/shareholder value and the social good. Environmental, social, and governance activities and investments have grown exponentially in recent decades.
Data democratization and self-service analytics are a gateway to companies’ data-driven decision-making in this post-digital transformation world. Rapid digitalization has altered the scope and scale of data usage across industries and throughout supply chains. Database structures and data management processes require accessible, accurate, and timely data, integrated from many sources to progress alongside this evolving landscape.